Drugs / Telminuvo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02526875 | Apr 2015 → Nov 2017 | hypertensive disorder | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Telminuvo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02526875 ↗ |
| Route | Oral | “per oral” NCT02526875 ↗ |